Cardiotrophin-Like Cytokine Factor 1 Exhibits a Myeloid-Biased Hematopoietic-Stimulating Function

Sarah Pasquin1, Aurélie Tormo1,2, Jessica Moreau1

  • 1Département de Pharmacologie et Physiologie, Université de Montréal, Montreal, QC, Canada.

Frontiers in Immunology
|September 26, 2019
PubMed

Insights

Cardiotrophin-like cytokine factor 1 (CLCF1) regulates hematopoiesis by increasing hematopoietic stem cells and myeloid cells. This discovery reveals a new role for CLCF1 in blood cell development and immune system function.

Area of Science:

  • Immunology
  • Hematology
  • Molecular Biology

Background:

  • Cardiotrophin-like cytokine factor 1 (CLCF1) forms a complex with CRLF1, and mutations in their genes are linked to immune system disorders.
  • CLCF1 influences B-cell expansion, humoral responses, and autoimmunity in mice.
  • Reduced CLCF1 secretion or CLCF1 deficiency leads to decreased progenitor cells and leukocytes, suggesting a role in hematopoiesis.

Purpose of the Study:

  • To investigate the potential role of CLCF1 in regulating hematopoiesis.
  • To determine the effects of CLCF1 on hematopoietic stem and progenitor cells (HSPCs) and myeloid cell differentiation.

Main Methods:

  • In vitro treatment of murine Lin-Sca1+c-kit+ (LSK) cells with CLCF1.
  • Administration of CLCF1 to healthy C57BL/6 mice.
  • CLCF1 administration to mice undergoing sub-lethal irradiation or bone marrow transplantation (BMT).

Main Results:

  • CLCF1 significantly increased LSK cell frequency and counts in vitro, potentially mediated by factors like IL-6, G-CSF, IL-1β, IL-10, and VEGF.
  • In vivo CLCF1 administration boosted circulating myeloid cells and increased LSK and myeloid cell counts in the bone marrow.
  • CLCF1 accelerated LSK recovery and sustained myeloid cell production post-irradiation or BMT.

Conclusions:

  • CLCF1 plays a significant and previously unrecognized role in regulating hematopoiesis.
  • CLCF1 promotes hematopoiesis with a specific bias towards myeloid cell differentiation.
  • CLCF1's influence on hematopoiesis has implications for immune system regulation and potential therapeutic applications.

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.0K
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
6.7K
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
82.3K
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.3K